National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

VEGFR-2 inhibitor CT-322 (... in-HIH-bih-ter ...)

 A substance being studied in the treatment of cancer. VEGFR-2 inhibitor CT-322 may prevent the growth of new blood vessels that tumors need to grow and may kill cancer cells. It is a type of vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor and a type of antiangiogenesis agent. Also called Angiocept and CT-322.



Previous Definitions:vegan, VEGF, VEGF Trap, VEGF-AS, VEGFR tyrosine kinase inhibitor
Next Definitions:vein, velafermin, Velban, Velcade, venipuncture

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov